PARIS (AP) News & REUTERS’ Dealtalk: A walk in the Alps put Genzyme deal on track …

MARSEILLE, France—Trophos SA has announced a €6 million ($8.05 million) European Union award to support MitoCare, a two-and-a-half year international, translational medicine project involving a 16-partner consortium to be led by Trophos, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology

Ryan McBride 11/8/10 Framingham, MA-based GTC Biotherapeutics, the first company to get FDA approval of a drug derived from genetically modified animals, has struck a stock purchase and merger deal with LFB Biotechnologies, according to a press release. France’s LFB…

* Orexigen to get upfront cash payment of $50 mln
* Deal can pay Orexigen over $1 bln in milestone payments
* Takeda to market obesity drug in U.S., Mexico, Canada
* Cos to share costs of any future product development
* Orexigen shares jump 23 pct (Adds analyst comment, background, updates share price)

In a Video Game, Tackling the Complexities of Protein Folding In a match that pitted video game players against the best known computer program designed for the task, the gamers outperformed the software in figuring out how 10 proteins fold…

By MARLEY SEAMAN AP Health Writer NEW YORK (AP) – Biotechnology company Celgene said Wednesday it is expanding its array of cancer treatments with a deal to buy Abraxis BioScience Inc. for $2.9 billion in cash and stock. Celgene Corp.…